{
  "ptid_time": "011_S_4235_2011-12-19",
  "img_path": "/data/qiuhui/data/adni/images/011_S_4235/2011-12-19/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 30,620 mm³, 2.0% above the reference mean. With a Z-score of 0.05 (51.9th percentile), this represents normal volume ; hippocampal volume measures 6,486 mm³, 19.2% below the reference mean. With a Z-score of -1.92 (2.8th percentile), this represents moderate atrophy; whole brain volume measures 1,198,510 mm³, 5.6% above the reference mean. With a Z-score of 0.80 (78.8th percentile), this represents normal volume ; entorhinal cortex volume measures 3,389 mm³, 20.5% below the reference mean. With a Z-score of -1.42 (7.8th percentile), this represents mild atrophy; fusiform gyrus volume measures 23,082 mm³, 15.9% above the reference mean. With a Z-score of 1.33 (90.7th percentile), this represents mild enlargement; middle temporal gyrus volume measures 22,088 mm³, 1.4% below the reference mean. With a Z-score of -0.12 (45.3th percentile), this represents normal volume . ",
  "text_data": "Age is 63.8 years. Gender is Male. Education: 16 years. Handedness: Right. Race: White. Medical history: Cardiovascular; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Smoking; Major Surgical Procedures. MMSE: 27.0. MoCA: 25.0. Logical Memory: 5.0. Laboratory findings: Monocytes: 0.76 (profound elevated); Monocytes: 9.70 (significant elevated); Alkaline Phosphatase: 29.00 (significant reduced); Triglycerides (GPO): 264.00 (significant elevated); ALT (SGPT): 34.00 (significant elevated). APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.47 SUVR (profound elevated); Amyloid beta: 697.20 pg/mL (normal ); Total tau: 298.80 pg/mL (normal ); Phosphorylated tau: 32.64 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal and entorhinal cortex volumes show significant atrophy (Z-scores of -1.92 and -1.42, respectively), which are key regions affected in Alzheimer's disease. The elevated AV45 (amyloid PET) and mildly elevated P-tau suggest amyloid pathology and neurodegeneration, while cognitive scores (MMSE 27, MoCA 25) indicate mild impairment.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer's pathology)  \n**Confidence:** **High**  \n\n(Note: The diagnosis is MCI rather than dementia due to preserved global cognition (MMSE 27) and only mild functional impact. The biomarker profile strongly supports underlying Alzheimer's pathology.)",
  "timestamp": "2025-07-25T22:56:05.072231"
}